Langer, H.T.* ; Rohm, M. ; Goncalves, M.D.* ; Sylow, L.*
AMPK as a mediator of tissue preservation: Time for a shift in dogma?
Nat. Rev. Endocrinol., DOI: 10.1038/s41574-024-00992-y (2024)
Ground-breaking discoveries have established 5'-AMP-activated protein kinase (AMPK) as a central sensor of metabolic stress in cells and tissues. AMPK is activated through cellular starvation, exercise and drugs by either directly or indirectly affecting the intracellular AMP (or ADP) to ATP ratio. In turn, AMPK regulates multiple processes of cell metabolism, such as the maintenance of cellular ATP levels, via the regulation of fatty acid oxidation, glucose uptake, glycolysis, autophagy, mitochondrial biogenesis and degradation, and insulin sensitivity. Moreover, AMPK inhibits anabolic processes, such as lipogenesis and protein synthesis. These findings support the notion that AMPK is a crucial regulator of cell catabolism. However, studies have revealed that AMPK's role in cell homeostasis might not be as unidirectional as originally thought. This Review explores emerging evidence for AMPK as a promoter of cell survival and an enhancer of anabolic capacity in skeletal muscle and adipose tissue during catabolic crises. We discuss AMPK-activating interventions for tissue preservation during tissue wasting in cancer-associated cachexia and explore the clinical potential of AMPK activation in wasting conditions. Overall, we provide arguments that call for a shift in the current dogma of AMPK as a mere regulator of cell catabolism, concluding that AMPK has an unexpected role in tissue preservation.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Review
Thesis type
Editors
Keywords
Activated Protein-kinase; Fatty-acid Oxidation; Stimulated Glucose-uptake; Brown Adipose-tissue; Exacerbates Insulin-resistance; Human Skeletal-muscle; Cancer Cachexia; Energy-charge; Endurance Exercise; Mammalian Target
Keywords plus
Language
english
Publication Year
2024
Prepublished in Year
0
HGF-reported in Year
2024
ISSN (print) / ISBN
1759-5029
e-ISSN
1759-5037
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume:
Issue:
Pages:
Article Number:
Supplement:
Series
Publisher
Nature Publishing Group
Publishing Place
New York, NY
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
90000 - German Center for Diabetes Research
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-501900-257
Grants
German Center for Diabetes Research (DZD)
National Cancer Institute
Novo Nordisk Foundation
Independent Research Council Denmark
Danish Cancer Society
Carlsberg Foundation
European Research Council (ERC) under the European Union
Helmholtz Association - Initiative and Networking Fund
European Foundation for the Study of Diabetes (EFSD)/ Novo Nordisk Foundation Future Leaders Award
Cancer Research UK
Copyright
Erfassungsdatum
2024-06-14